 |
| |
| |
| Discover our ECCMID 2024 Symposiums & Programme |
| |
| This ECCMID 2024, deep dive into the real-world impact of molecular diagnostics on patient care, explore a 360-degree holistic view on the tackling of some of the largest threats facing healthcare systems today, and discover our unique “meet the expert” presentation opportunities. |
| |
|
|
|
|
|
| |
|
|
Sunday, 28th April 2024 — 13.30-15.30
|
| "Innovating rapid molecular diagnostics for infectious diseases: real world impact on patient care" |
| |
Chair: Dr. Beryl Oppenheim, Senior Director Medical Affairs, Cepheid, UK
ESCMID-appointed Chair: Dr. Mariska Leeflang, Associate Professor, Amsterdam UMC, Netherlands
Speakers:
- Tristan Clark, Professor and Honorary Consultant in Infectious Diseases, University Hospital Southampton NHS Foundation Trust, UK
- Clemens Kill, Director, Center of Emergency Medicine Essen University, Germany
- Valeria Cento, Associate Professor of Microbiology, Humanitas Research Hospital, Italy
- Elena Reigadas, Microbiologist, Hospital General Universitario Gregorio Marañón, Spain
|
|
|
|
|
|
| |
|
|
Monday, 29th April 2024 — 12.15-13.15
|
| "Tackling antimicrobial resistance in Europe: prevention through diagnostics as the best defense" |
| |
Chair: Dr. Beryl Oppenheim, Senior Director Medical Affairs, Cepheid, UK
ESCMID-appointed Chair: Dr. Truls Leegaard, Consultant Microbiologist, Akershus University Hospital, Norway
Speakers:
- Olga Jonas, Economist Former Advisor World Bank, Sr. Fellow Harvard University, France
- Andrew Ullmann, MP Member of German Bundestag, UNITE Network, Germany
- José Artur Paiva, Director Intensive Care Medicine Service, Centro Hospitalar Universitário São João, Portugal
- Venessa Carter, AMR Patient Survivor and One Health Advocate, The AMR Narrative, UK
|
|
|
|
|
|
| |
|
| Meet the Expert: Dr. Frédéric Janvier |
| Sunday, 28th April 2024 — Lunch time |
| |
“Strategy for using Xpert® Carba-R PCR on admission of EPC-suspect patients: 2020-2023 study”
Dr. Frédéric Janvier, Chief Medical Officer (COL), Associate Professor
Val-de-Grâce Hospital, France |
| |
|
|
|
| |
| Meet the Expert: Dr. Jan Gorm Lisby |
| Monday, 29th April 2024 — Lunch time |
| |
“Considerations regarding evaluation of point of care molecular tests for respiratory viruses”
Dr. Jan Gorm Lisby, Chief Consultant Dept. of Clinical Microbiology
Hvidovre Hospital, Denmark |
|
|
|
| |
| |
| |
|
| |
We look forward to seeing you at ECCMID 2024, in-person and virtually
April 27-30, 2024, Barcelona, Spain.
Visit your Cepheid team at Booth #C8 to explore Cepheid's latest developments in respiratory testing, wider infectious disease and antimicrobial resistance management, and standardised laboratory and decentralised testing. |
| |
|
|
|
| |
| |
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
|
|
 |
About Cepheid
|
| Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform advanced PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most - from central laboratories and hospitals to near-patient settings. |
| For more information, visit www.cepheid.com. |
|
|
| About Cepheid | Privacy Policy | Contact Us
|
Cepheid UK Ltd.
© 2024 Cepheid. All Rights Reserved. |
| |
|
|
|
|
|
|
